Details for New Drug Application (NDA): 050347
✉ Email this page to a colleague
NDA 050347 describes TROBICIN, which is a drug marketed by Pfizer and is included in one NDA. Additional details are available on the TROBICIN profile page.
The generic ingredient in TROBICIN is spectinomycin hydrochloride. There are four drug master file entries for this compound. Additional details are available on the spectinomycin hydrochloride profile page.
The generic ingredient in TROBICIN is spectinomycin hydrochloride. There are four drug master file entries for this compound. Additional details are available on the spectinomycin hydrochloride profile page.
Summary for 050347
| Tradename: | TROBICIN |
| Applicant: | Pfizer |
| Ingredient: | spectinomycin hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 050347
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 2GM BASE/VIAL | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 4GM BASE/VIAL | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
